Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Samantha MaWhinney

Concepts (510)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
87
2025
2821
4.590
Why?
Anti-HIV Agents
40
2025
773
3.930
Why?
Adenine
16
2025
268
2.100
Why?
Emtricitabine
16
2025
175
2.070
Why?
Tenofovir
18
2025
241
1.880
Why?
Organophosphates
13
2025
134
1.820
Why?
Acquired Immunodeficiency Syndrome
10
2023
232
1.590
Why?
HIV-1
31
2021
862
1.510
Why?
Dried Blood Spot Testing
9
2024
103
1.440
Why?
Patient Dropouts
3
2025
67
1.130
Why?
Pre-Exposure Prophylaxis
8
2025
213
0.890
Why?
Medication Adherence
12
2025
468
0.890
Why?
Viral Load
20
2022
464
0.670
Why?
Directly Observed Therapy
1
2017
15
0.570
Why?
Middle Aged
68
2025
33225
0.520
Why?
Adult
64
2025
37626
0.500
Why?
Anti-Retroviral Agents
5
2019
232
0.490
Why?
Humans
129
2025
136750
0.480
Why?
Leukocytes, Mononuclear
9
2021
558
0.470
Why?
Pulmonary Disease, Chronic Obstructive
1
2023
1036
0.470
Why?
Aging
9
2023
1863
0.460
Why?
Male
81
2025
67305
0.450
Why?
Zidovudine
3
2012
78
0.430
Why?
Lamivudine
3
2012
63
0.430
Why?
Female
80
2025
72785
0.420
Why?
Unsafe Sex
2
2012
59
0.420
Why?
Viremia
6
2022
138
0.410
Why?
Cytochrome P-450 CYP3A
2
2012
88
0.390
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
2025
19
0.390
Why?
CD8-Positive T-Lymphocytes
9
2018
913
0.370
Why?
T-Lymphocytes, Cytotoxic
6
2014
173
0.370
Why?
Sofosbuvir
4
2022
59
0.370
Why?
Oligopeptides
2
2012
271
0.360
Why?
Exercise
6
2022
2044
0.350
Why?
Atazanavir Sulfate
4
2016
41
0.350
Why?
Sustained Virologic Response
3
2019
40
0.340
Why?
Models, Statistical
5
2022
668
0.340
Why?
Prospective Studies
23
2022
7572
0.340
Why?
HIV Integrase Inhibitors
2
2024
70
0.330
Why?
Receptors, CCR5
6
2013
59
0.330
Why?
Dideoxynucleotides
2
2012
14
0.320
Why?
Cytidine Triphosphate
2
2012
16
0.320
Why?
CD4-Positive T-Lymphocytes
9
2016
1095
0.320
Why?
Mobile Applications
2
2022
182
0.320
Why?
Phosphorous Acids
2
2019
12
0.320
Why?
Pyridines
2
2012
506
0.320
Why?
Emigrants and Immigrants
1
2012
138
0.310
Why?
Levonorgestrel
2
2012
38
0.310
Why?
Antiviral Agents
3
2019
738
0.300
Why?
Frailty
2
2022
170
0.300
Why?
Sarcoma, Kaposi
3
2022
81
0.290
Why?
Antiretroviral Therapy, Highly Active
8
2019
271
0.290
Why?
Longitudinal Studies
7
2025
2829
0.290
Why?
Quality of Life
7
2023
2876
0.280
Why?
Gonadal Steroid Hormones
1
2008
140
0.270
Why?
Lymphocyte Activation
10
2018
1150
0.260
Why?
Exercise Therapy
3
2020
436
0.260
Why?
Deoxyadenine Nucleotides
2
2016
14
0.260
Why?
Prion Diseases
1
2006
15
0.260
Why?
Deoxycytosine Nucleotides
2
2016
11
0.260
Why?
Creutzfeldt-Jakob Syndrome
1
2006
19
0.260
Why?
Wasting Disease, Chronic
1
2006
26
0.260
Why?
Coronary Artery Bypass
8
2004
233
0.250
Why?
Inflammation
5
2021
2835
0.250
Why?
Lymph Nodes
6
2017
492
0.250
Why?
Aged
26
2023
23800
0.250
Why?
Data Interpretation, Statistical
2
2025
363
0.250
Why?
Young Adult
17
2025
13126
0.240
Why?
Gene Expression
2
2014
1500
0.240
Why?
Simian Immunodeficiency Virus
2
2016
88
0.230
Why?
CD4 Lymphocyte Count
11
2020
268
0.230
Why?
Body Composition
4
2024
678
0.230
Why?
Simian Acquired Immunodeficiency Syndrome
2
2016
86
0.230
Why?
Bias
2
2025
218
0.230
Why?
HIV
4
2019
234
0.220
Why?
Contraceptives, Postcoital
1
2004
2
0.220
Why?
Cross-Over Studies
4
2020
562
0.220
Why?
Computer Simulation
4
2025
973
0.220
Why?
Advance Care Planning
2
2021
208
0.210
Why?
Population Surveillance
3
2002
473
0.210
Why?
Cytokines
3
2009
2084
0.210
Why?
Cohort Studies
8
2023
5703
0.210
Why?
Physical Fitness
2
2015
208
0.210
Why?
Lipopolysaccharide Receptors
2
2021
85
0.210
Why?
HIV Integrase
1
2024
70
0.200
Why?
Fluorenes
2
2020
42
0.200
Why?
HIV Seropositivity
3
2012
125
0.190
Why?
Drug Resistance, Viral
2
2019
115
0.190
Why?
High-Intensity Interval Training
1
2022
25
0.190
Why?
Telerehabilitation
1
2022
37
0.190
Why?
Cell Phone
1
2022
75
0.190
Why?
Lymphoid Tissue
3
2008
75
0.190
Why?
RNA, Viral
9
2014
654
0.190
Why?
Benzimidazoles
2
2020
168
0.180
Why?
Hepatitis C
2
2022
266
0.180
Why?
Alanine
4
2024
151
0.180
Why?
Hair
2
2018
84
0.180
Why?
Protease Inhibitors
2
2020
106
0.180
Why?
Fees and Charges
1
2000
10
0.170
Why?
Polyphosphates
4
2022
36
0.170
Why?
Ritonavir
2
2012
74
0.170
Why?
Hyperlipidemias
1
2021
120
0.170
Why?
Advance Directives
1
2021
72
0.160
Why?
Mitochondria, Muscle
1
2021
116
0.160
Why?
Interleukin-10
2
2021
302
0.160
Why?
Costs and Cost Analysis
1
2000
205
0.160
Why?
Research Design
2
2025
1127
0.160
Why?
ADP-ribosyl Cyclase 1
4
2013
38
0.160
Why?
Thymine Nucleotides
2
2016
16
0.150
Why?
Biomarkers
7
2021
4145
0.150
Why?
Myocardial Ischemia
1
2000
262
0.150
Why?
Cytomegalovirus Infections
2
2015
191
0.150
Why?
Hepatitis C, Chronic
2
2019
163
0.150
Why?
Blood Chemical Analysis
4
2019
98
0.150
Why?
Colorado
7
2022
4512
0.140
Why?
Simeprevir
1
2018
9
0.140
Why?
Raltegravir Potassium
2
2015
17
0.140
Why?
Transgender Persons
1
2021
182
0.140
Why?
Heterocyclic Compounds, 3-Ring
1
2018
32
0.140
Why?
Virus Replication
5
2017
482
0.140
Why?
Epitopes, T-Lymphocyte
4
2008
187
0.140
Why?
Viral Tropism
1
2017
31
0.140
Why?
Sleep Wake Disorders
1
2020
283
0.130
Why?
Pharmacogenetics
2
2016
179
0.130
Why?
AIDS-Related Opportunistic Infections
3
2007
126
0.130
Why?
Length of Stay
4
2000
1204
0.130
Why?
Pyrophosphatases
1
2016
28
0.130
Why?
Deoxyguanine Nucleotides
1
2016
11
0.130
Why?
T-Lymphocytes, Helper-Inducer
1
2017
137
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2021
443
0.130
Why?
Genitalia
1
2016
30
0.130
Why?
Academic Medical Centers
1
2019
503
0.130
Why?
Germinal Center
1
2016
58
0.130
Why?
Motor Activity
4
2015
717
0.130
Why?
Vaccines, DNA
2
2008
32
0.130
Why?
Ribavirin
1
2016
91
0.120
Why?
HIV Protease Inhibitors
2
2016
69
0.120
Why?
AIDS Vaccines
2
2008
52
0.120
Why?
Purines
1
2016
176
0.120
Why?
Muscle Strength
1
2018
315
0.120
Why?
Risk Factors
11
2021
10330
0.120
Why?
Disease Transmission, Infectious
2
2018
62
0.120
Why?
Biometry
2
2011
70
0.120
Why?
T-Lymphocyte Subsets
4
2015
425
0.120
Why?
HLA-DR Antigens
3
2012
228
0.120
Why?
Case-Control Studies
7
2016
3540
0.120
Why?
Genitalia, Female
1
2015
38
0.120
Why?
Rectum
1
2016
185
0.120
Why?
Antibodies, Viral
3
2015
623
0.110
Why?
Mental Health Services
1
2019
416
0.110
Why?
Organophosphonates
1
2015
93
0.110
Why?
Linear Models
4
2020
845
0.110
Why?
Probability
2
2011
304
0.110
Why?
T-Lymphocytes, Regulatory
1
2017
387
0.110
Why?
Calcifediol
1
2014
33
0.110
Why?
Sexual and Gender Minorities
1
2017
213
0.110
Why?
Deoxycytidine
1
2015
179
0.110
Why?
Calcitriol
1
2014
58
0.110
Why?
Immunoglobulin Variable Region
1
2014
80
0.110
Why?
Antimicrobial Cationic Peptides
1
2014
81
0.110
Why?
Membrane Glycoproteins
3
2013
500
0.110
Why?
Telemedicine
1
2022
852
0.110
Why?
Disease Progression
4
2015
2751
0.110
Why?
Patient Compliance
1
2017
577
0.100
Why?
Decision Making
1
2021
898
0.100
Why?
Multivariate Analysis
8
2007
1507
0.100
Why?
Adolescent
14
2020
21380
0.100
Why?
Gastrointestinal Microbiome
1
2021
698
0.100
Why?
Chromatography, Liquid
3
2019
432
0.100
Why?
Microbiota
1
2021
762
0.100
Why?
Immunoglobulin G
2
2015
887
0.100
Why?
Immunologic Factors
1
2015
236
0.100
Why?
Time Factors
8
2019
6808
0.100
Why?
Infectious Disease Transmission, Vertical
1
1994
182
0.100
Why?
Spleen
1
2014
514
0.100
Why?
Emergency Service, Hospital
1
2004
2047
0.100
Why?
Hepatitis A Vaccines
1
2012
15
0.100
Why?
Dendritic Cells
2
2008
484
0.100
Why?
Hepatitis A
1
2012
26
0.100
Why?
Benzoxazines
1
2012
31
0.090
Why?
Diabetes Mellitus
1
2020
1033
0.090
Why?
Numerical Analysis, Computer-Assisted
2
2002
19
0.090
Why?
Cervix Uteri
1
2012
48
0.090
Why?
Tandem Mass Spectrometry
3
2019
531
0.090
Why?
Sarcopenia
1
2013
82
0.090
Why?
Cell Movement
3
2016
968
0.090
Why?
Marijuana Smoking
1
2015
249
0.090
Why?
Contraceptive Agents
1
2012
66
0.090
Why?
Haplotypes
2
2012
494
0.090
Why?
Benchmarking
2
2024
183
0.090
Why?
Muscle, Skeletal
1
2021
1707
0.090
Why?
B-Lymphocytes
1
2016
846
0.090
Why?
Polymorphism, Genetic
2
2016
659
0.090
Why?
CD4 Antigens
1
2011
142
0.090
Why?
Retrospective Studies
9
2021
15499
0.090
Why?
Mental Disorders
1
2019
1070
0.090
Why?
Contraceptive Agents, Female
1
2012
80
0.090
Why?
Sex Factors
5
2018
2064
0.090
Why?
HIV Seronegativity
1
2010
28
0.090
Why?
Antacids
1
2010
16
0.090
Why?
Pyrrolidinones
1
2010
28
0.090
Why?
Hypertension, Pulmonary
1
2022
1904
0.090
Why?
Drug Monitoring
2
2022
218
0.090
Why?
Osteoporosis
1
2013
243
0.080
Why?
Accidental Falls
1
2012
193
0.080
Why?
Herpesvirus 8, Human
2
2000
65
0.080
Why?
Postmenopause
1
2012
365
0.080
Why?
Cross-Sectional Studies
8
2019
5419
0.080
Why?
Diphosphates
2
2021
17
0.080
Why?
Predictive Value of Tests
4
2019
2021
0.080
Why?
Cytomegalovirus
2
2015
157
0.080
Why?
Zimbabwe
3
2022
55
0.080
Why?
Drug Interactions
3
2019
406
0.080
Why?
Complementarity Determining Regions
2
2014
51
0.080
Why?
Cytotoxicity Tests, Immunologic
3
2003
41
0.070
Why?
Molecular Sequence Data
3
2009
2894
0.070
Why?
Polymorphism, Single Nucleotide
2
2016
2184
0.070
Why?
Demography
2
2022
291
0.070
Why?
Sequence Analysis, DNA
2
2009
809
0.070
Why?
Lung Diseases
1
2015
768
0.070
Why?
Hepacivirus
2
2022
260
0.070
Why?
Mutation
2
2014
3947
0.070
Why?
Healthy Volunteers
2
2018
199
0.070
Why?
Plasma
1
2009
213
0.070
Why?
Interleukin-12
2
1998
121
0.070
Why?
Hospitals, Veterans
3
2004
249
0.070
Why?
Managed Care Programs
1
2007
130
0.060
Why?
Deer
1
2006
32
0.060
Why?
Adipocytes
1
2008
222
0.060
Why?
Interferon-gamma
3
2008
789
0.060
Why?
Comorbidity
3
2019
1614
0.060
Why?
Therapeutic Equivalency
2
2018
32
0.060
Why?
Treatment Outcome
10
2018
10747
0.060
Why?
Self Report
2
2021
822
0.060
Why?
Physicians, Family
1
2007
201
0.060
Why?
Preventive Health Services
1
2007
148
0.060
Why?
Interleukin-6
2
2021
778
0.060
Why?
Kenya
1
2025
115
0.060
Why?
Macaca mulatta
2
2016
166
0.060
Why?
Flow Cytometry
4
2015
1180
0.060
Why?
Immunoenzyme Techniques
1
2005
219
0.060
Why?
Incidence
4
2012
2797
0.060
Why?
T-Lymphocytes
3
2005
1993
0.060
Why?
Area Under Curve
2
2018
314
0.060
Why?
Licensure, Pharmacy
1
2004
1
0.060
Why?
Northern Ireland
1
2004
7
0.060
Why?
Immunologic Memory
2
2009
370
0.050
Why?
New York City
2
1994
85
0.050
Why?
Programmed Cell Death 1 Receptor
2
2016
250
0.050
Why?
Pilot Projects
3
2022
1693
0.050
Why?
Odds Ratio
3
2014
1065
0.050
Why?
Fluorescent Antibody Technique
3
2015
388
0.050
Why?
Hospitalization
3
2022
2181
0.050
Why?
Survival Analysis
3
2015
1321
0.050
Why?
HIV Antibodies
2
2014
62
0.050
Why?
Conserved Sequence
1
2003
239
0.050
Why?
Ki-67 Antigen
2
2017
111
0.050
Why?
Patient Satisfaction
1
2007
656
0.050
Why?
Integrases
1
2024
120
0.050
Why?
Surveys and Questionnaires
2
2014
5739
0.050
Why?
Tablets
1
2022
40
0.050
Why?
Quality of Health Care
1
2007
633
0.050
Why?
Reverse Transcriptase Inhibitors
1
2002
84
0.050
Why?
Creatinine
3
2018
498
0.050
Why?
Likelihood Functions
3
2001
143
0.050
Why?
Cells, Cultured
4
2017
4192
0.050
Why?
Drug Therapy, Combination
2
2018
1062
0.050
Why?
Models, Biological
2
2016
1773
0.050
Why?
Drug Prescriptions
1
2004
244
0.050
Why?
Bayes Theorem
2
2020
404
0.050
Why?
Habits
1
2022
49
0.050
Why?
Voltage-Dependent Anion Channel 1
1
2021
10
0.050
Why?
Sex Characteristics
1
2007
763
0.050
Why?
Angina Pectoris
1
2001
65
0.050
Why?
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
1
2021
42
0.050
Why?
Citrate (si)-Synthase
1
2021
60
0.050
Why?
Phenotype
4
2016
3189
0.050
Why?
Antigens, Viral
3
2014
181
0.040
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
42
0.040
Why?
Mental Health
2
2019
716
0.040
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
87
0.040
Why?
Diagnosis-Related Groups
1
2000
30
0.040
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
337
0.040
Why?
Hand Strength
1
2021
122
0.040
Why?
Hemarthrosis
1
2000
21
0.040
Why?
HIV Antigens
2
2015
18
0.040
Why?
Actigraphy
1
2020
110
0.040
Why?
Heart Valves
1
2000
43
0.040
Why?
Weight Gain
1
2024
519
0.040
Why?
Death
1
2021
119
0.040
Why?
Weight Loss
2
2020
776
0.040
Why?
Communicable Diseases
1
2002
159
0.040
Why?
Virus Diseases
1
2002
213
0.040
Why?
Immunophenotyping
3
2007
319
0.040
Why?
Drug Combinations
1
2020
343
0.040
Why?
Amino Acid Motifs
2
2014
225
0.040
Why?
Superoxide Dismutase
1
2021
346
0.040
Why?
Sickness Impact Profile
1
1999
56
0.040
Why?
Age Factors
3
2000
3286
0.040
Why?
Regression Analysis
2
2007
1022
0.040
Why?
Survivors
1
2022
487
0.040
Why?
Capsules
1
2018
38
0.040
Why?
Cytotoxicity, Immunologic
3
2007
225
0.040
Why?
Herpesviridae Infections
1
1999
149
0.040
Why?
Feasibility Studies
1
2022
949
0.040
Why?
Uganda
1
2018
73
0.040
Why?
Renal Insufficiency
1
2000
155
0.040
Why?
Chemoprevention
1
2018
92
0.040
Why?
Drug Compounding
1
2018
101
0.040
Why?
Chemistry Techniques, Analytical
1
2018
21
0.040
Why?
Nanomedicine
1
2018
47
0.040
Why?
Hemophilia A
1
2000
139
0.040
Why?
Metabolic Clearance Rate
1
2018
115
0.040
Why?
Oxazines
1
2018
30
0.040
Why?
Fluconazole
1
1997
19
0.040
Why?
Histoplasmosis
1
1997
17
0.040
Why?
Heart Diseases
2
2000
346
0.030
Why?
Early Detection of Cancer
1
2022
417
0.030
Why?
Fibrin Fibrinogen Degradation Products
1
2018
82
0.030
Why?
Severity of Illness Index
3
2000
2819
0.030
Why?
Aged, 80 and over
2
2021
7593
0.030
Why?
Cardiology Service, Hospital
1
1997
24
0.030
Why?
Adaptation, Physiological
1
2021
549
0.030
Why?
Internet
1
2002
647
0.030
Why?
Cause of Death
1
2019
429
0.030
Why?
Palatine Tonsil
1
2017
48
0.030
Why?
Inosine Triphosphate
1
2016
2
0.030
Why?
Fatigue
1
2019
326
0.030
Why?
Anemia, Hemolytic
1
2016
20
0.030
Why?
Perforin
1
2016
19
0.030
Why?
Clinical Studies as Topic
1
2016
10
0.030
Why?
Genotype
3
2012
1914
0.030
Why?
Antifungal Agents
1
1997
136
0.030
Why?
Guanosine Triphosphate
1
2016
91
0.030
Why?
Models, Theoretical
1
2000
574
0.030
Why?
Primary Health Care
1
2007
1722
0.030
Why?
Half-Life
1
2016
164
0.030
Why?
Child
7
2017
21816
0.030
Why?
Lymphocyte Depletion
1
2016
135
0.030
Why?
Machine Learning
1
2021
488
0.030
Why?
Pyridones
1
2018
168
0.030
Why?
Prognosis
2
2021
4012
0.030
Why?
Lung
2
2022
4061
0.030
Why?
Eating
1
1999
379
0.030
Why?
Peru
1
2016
58
0.030
Why?
Nucleotides
1
2016
124
0.030
Why?
Statistics, Nonparametric
2
2012
431
0.030
Why?
United States
6
2016
14682
0.030
Why?
Heart Valve Prosthesis Implantation
1
1998
180
0.030
Why?
Spermatozoa
1
2016
94
0.030
Why?
Forkhead Transcription Factors
1
2016
190
0.030
Why?
Clinical Protocols
1
1997
267
0.030
Why?
Randomized Controlled Trials as Topic
1
2022
1462
0.030
Why?
Tumor Necrosis Factor-alpha
1
2021
1242
0.030
Why?
Intubation, Intratracheal
1
1998
257
0.030
Why?
Algorithms
2
2011
1688
0.030
Why?
Human Activities
1
2015
21
0.030
Why?
Piperazines
1
2018
350
0.030
Why?
South Africa
1
2016
219
0.030
Why?
Animals
4
2016
36836
0.030
Why?
Receptors, CXCR4
2
2007
86
0.030
Why?
Drug Users
1
2015
40
0.030
Why?
Receptors, CXCR5
1
2014
21
0.030
Why?
Receptors, CCR7
1
2014
32
0.030
Why?
Blood
1
2015
106
0.030
Why?
HEK293 Cells
1
2017
729
0.030
Why?
Drug Administration Schedule
1
2016
785
0.030
Why?
Cathelicidins
1
2014
41
0.030
Why?
Adenosine Triphosphate
1
2016
487
0.030
Why?
Registries
1
2022
2014
0.030
Why?
Polymerase Chain Reaction
2
2012
1059
0.030
Why?
Mutation Rate
1
2014
29
0.030
Why?
Child, Preschool
4
2002
10997
0.030
Why?
Substance Abuse, Intravenous
1
2015
114
0.030
Why?
Gene Expression Regulation, Viral
1
2014
93
0.030
Why?
Aging, Premature
1
2013
13
0.030
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
39
0.030
Why?
Body Fat Distribution
1
2013
49
0.030
Why?
Kidney Failure, Chronic
1
1999
566
0.030
Why?
Infant
3
2002
9395
0.030
Why?
Amino Acid Substitution
1
2014
306
0.020
Why?
Energy Metabolism
1
1999
919
0.020
Why?
Mothers
1
1999
752
0.020
Why?
Infant, Newborn
2
1994
6031
0.020
Why?
Frail Elderly
1
2013
132
0.020
Why?
Muscles
1
2013
325
0.020
Why?
Clone Cells
2
2002
266
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2015
654
0.020
Why?
Cyclopropanes
1
2012
90
0.020
Why?
Alkynes
1
2012
56
0.020
Why?
Receptors, HIV
1
2011
24
0.020
Why?
Confidence Intervals
1
2012
328
0.020
Why?
Cardiac Surgical Procedures
1
1997
530
0.020
Why?
Insulin-Like Growth Factor I
1
2013
316
0.020
Why?
Bone and Bones
1
2013
316
0.020
Why?
Geography
1
2011
198
0.020
Why?
Follow-Up Studies
2
2015
5105
0.020
Why?
Pregnancy Complications, Infectious
1
1994
389
0.020
Why?
Epithelial Cells
1
2016
1094
0.020
Why?
Disease Susceptibility
1
2012
345
0.020
Why?
Chi-Square Distribution
2
2002
530
0.020
Why?
Depression
1
2019
1397
0.020
Why?
North America
1
2011
311
0.020
Why?
Postoperative Complications
1
2001
2639
0.020
Why?
Interleukin-2
2
2003
455
0.020
Why?
Cost-Benefit Analysis
1
2012
587
0.020
Why?
Bone Density
1
2013
487
0.020
Why?
Body Mass Index
2
2013
2373
0.020
Why?
Cell Proliferation
1
2016
2476
0.020
Why?
Postoperative Hemorrhage
2
2000
86
0.020
Why?
United States Department of Veterans Affairs
2
2004
674
0.020
Why?
DNA, Viral
2
2000
363
0.020
Why?
Magnetic Resonance Imaging
1
2000
3556
0.020
Why?
Respiratory Tract Diseases
2
2000
184
0.020
Why?
Health Status
2
2004
788
0.020
Why?
Socioeconomic Factors
1
2012
1282
0.020
Why?
Personnel Turnover
1
2007
40
0.020
Why?
Gene Expression Regulation
1
2016
2605
0.020
Why?
DNA Primers
1
2008
514
0.020
Why?
Lymphocyte Count
1
2007
150
0.020
Why?
Immunosuppressive Agents
1
2012
889
0.020
Why?
Sweating
1
2007
40
0.020
Why?
Risk Assessment
3
2004
3432
0.020
Why?
Hospital Mortality
2
2004
901
0.020
Why?
Gender Identity
1
2007
124
0.020
Why?
Fever
1
2007
306
0.010
Why?
Health Care Surveys
1
2007
562
0.010
Why?
Obesity
1
1999
2982
0.010
Why?
Selection Bias
1
2005
37
0.010
Why?
DNA
1
2012
1458
0.010
Why?
Quality Indicators, Health Care
1
2007
307
0.010
Why?
Acute Disease
1
2007
1007
0.010
Why?
Neoplasms
1
2019
2643
0.010
Why?
Base Sequence
1
2008
2179
0.010
Why?
Cell Line
2
2001
2838
0.010
Why?
HLA-A3 Antigen
1
2003
6
0.010
Why?
HLA-B7 Antigen
1
2003
7
0.010
Why?
HLA-A2 Antigen
1
2003
48
0.010
Why?
Superantigens
1
2003
70
0.010
Why?
Intraoperative Care
1
2004
49
0.010
Why?
Histocompatibility Testing
1
2003
126
0.010
Why?
Cell Line, Transformed
1
2003
145
0.010
Why?
Virus Activation
1
2003
88
0.010
Why?
Double-Blind Method
1
2008
1982
0.010
Why?
B7-2 Antigen
1
2002
27
0.010
Why?
Drug Evaluation, Preclinical
1
2003
184
0.010
Why?
Postoperative Period
1
2004
343
0.010
Why?
Chronic Disease
1
2009
1786
0.010
Why?
Morbidity
1
2004
322
0.010
Why?
Genes, T-Cell Receptor beta
1
2002
22
0.010
Why?
Parainfluenza Virus 3, Human
1
2002
5
0.010
Why?
Community Medicine
1
2002
6
0.010
Why?
Hospital-Physician Relations
1
2002
4
0.010
Why?
Rotavirus
1
2002
20
0.010
Why?
CD40 Antigens
1
2002
89
0.010
Why?
Attitude to Computers
1
2002
29
0.010
Why?
Sick Role
1
2001
18
0.010
Why?
HIV Core Protein p24
1
2001
31
0.010
Why?
Immunity, Cellular
1
2003
268
0.010
Why?
Streptococcus pyogenes
1
2002
45
0.010
Why?
Pregnancy
1
1994
6727
0.010
Why?
Preoperative Care
1
2004
356
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2003
851
0.010
Why?
Respiratory Syncytial Virus, Human
1
2002
74
0.010
Why?
Health Services Research
1
2004
400
0.010
Why?
Nonlinear Dynamics
1
2001
88
0.010
Why?
Phosphorus Radioisotopes
1
2000
30
0.010
Why?
Elbow
1
2000
55
0.010
Why?
Community-Acquired Infections
1
2002
169
0.010
Why?
Ankle
1
2000
60
0.010
Why?
Antigens, CD
1
2002
521
0.010
Why?
Knee
1
2000
68
0.010
Why?
Hyperplasia
1
2000
175
0.010
Why?
Hemophilia B
1
2000
61
0.010
Why?
Forecasting
1
2001
388
0.010
Why?
Synovial Membrane
1
2000
117
0.010
Why?
Seasons
1
2002
544
0.010
Why?
Calorimetry, Indirect
1
1999
84
0.010
Why?
Diet Records
1
1999
83
0.010
Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.010
Why?
Fathers
1
1999
50
0.010
Why?
Cost Control
1
1998
39
0.010
Why?
Mice, Transgenic
1
2003
2163
0.010
Why?
Amino Acid Sequence
1
2002
2138
0.010
Why?
Anthropometry
1
1999
213
0.010
Why?
Activities of Daily Living
1
2001
414
0.010
Why?
Erythrocyte Transfusion
1
2000
193
0.010
Why?
Absorptiometry, Photon
1
1999
254
0.010
Why?
Radiography
1
2000
822
0.010
Why?
Puberty
1
1999
146
0.010
Why?
Analysis of Variance
1
2000
1316
0.010
Why?
Streptokinase
1
1996
10
0.010
Why?
Phytohemagglutinins
1
1996
30
0.010
Why?
Reproducibility of Results
1
2005
3264
0.010
Why?
Tetanus Toxoid
1
1996
35
0.010
Why?
Candida
1
1996
36
0.010
Why?
Cell Division
1
1998
796
0.010
Why?
Postoperative Care
1
1998
261
0.010
Why?
Disease-Free Survival
1
1997
686
0.010
Why?
Antigens, Bacterial
1
1996
129
0.010
Why?
Exercise Test
1
1999
625
0.010
Why?
Survival Rate
1
2000
1962
0.010
Why?
Logistic Models
1
2000
2067
0.010
Why?
Nuclear Proteins
1
1999
712
0.010
Why?
Adipose Tissue
1
1999
630
0.010
Why?
Patient Selection
1
1997
691
0.010
Why?
Databases, Factual
1
1999
1351
0.010
Why?
Recombinant Proteins
1
1996
1350
0.010
Why?
Prevalence
1
1999
2708
0.010
Why?
Mice
1
2003
17758
0.000
Why?
MaWhinney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)